Clinical trial
Orlistat Treatment of Unconjugated Hyperbilirubinemia in Crigler-Najjar Disease; A Randomized Controlled Trial
NCT00461799 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Orlistat Treatment of Unconjugated Hyperbilirubinemia in Crigler-Najjar Disease; A Randomized Controlled Trial
- Lead sponsor
- University Medical Center Groningen
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2003
- Completion date
- January 31, 2004
- Enrollment
- 16
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.